Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Daratumumab industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Johnson＆Johnson
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
100mg Injection
400mg Injection
Application:
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Daratumumab Industry Overview
-
1.1.1 Daratumumab Market Scope and Market Segments
-
1.1.2 Daratumumab Industry Characteristics
-
1.1.3 Global and China Daratumumab Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Daratumumab Production Value and Growth Rate (2017-2028)
-
1.2 Global Daratumumab Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 100mg Injection
-
1.2.2 400mg Injection
-
1.3 Global Daratumumab Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Multiple Myeloma
-
1.3.2 Diffuse Large B Cell Lymphoma
-
1.3.3 Follicular Lymphoma
-
1.3.4 Mantle Cell Lymphoma
-
1.3.5 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Daratumumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Daratumumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Daratumumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Daratumumab Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Daratumumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Daratumumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Daratumumab Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Daratumumab Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Daratumumab Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Daratumumab Industry Porter's Five Forces Model Analysis
-
2.2.3 Daratumumab Industry PEST Analysis
-
2.3 Daratumumab Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Daratumumab Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Daratumumab Industry
Chapter 3 Global and China Daratumumab Market, by Manufacturer
-
3.1 Global and China Daratumumab Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Daratumumab Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Daratumumab Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Daratumumab Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Daratumumab Market Top 3 Players
Chapter 4 Global and China Daratumumab Market, by Type (2017-2028)
-
4.1 Daratumumab Market Trend, by Type
-
4.2 Global Daratumumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Daratumumab Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Daratumumab Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Daratumumab Price Trend, by Type (2017-2028)
-
4.3 China Daratumumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Daratumumab Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Daratumumab Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Daratumumab Price Trend, by Type (2017-2028)
Chapter 5 Global and China Daratumumab Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Daratumumab Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Daratumumab Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Daratumumab Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Daratumumab Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Daratumumab Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Daratumumab Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Daratumumab Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Daratumumab Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Daratumumab Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Daratumumab Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Daratumumab Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Daratumumab Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Daratumumab Market Analysis
-
7.1 North America Daratumumab Market, by Type
-
7.2 North America Daratumumab Market, by Application
-
7.3 North America Daratumumab Market Analysis and Forecast, by Country
-
7.3.1 United States Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Daratumumab Market Analysis
-
8.1 Europe Daratumumab Market, by Type
-
8.2 Europe Daratumumab Market, by Application
-
8.3 Europe Daratumumab Market Analysis and Forecast, by Country
-
8.3.1 Germany Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Daratumumab Market Analysis
-
9.1 APAC Daratumumab Market, by Type
-
9.2 APAC Daratumumab Market, by Application
-
9.3 APAC Daratumumab Market Analysis and Forecast, by Country
-
9.3.1 China Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Daratumumab Market Analysis
-
10.1 Latin America, Middle East and Africa Daratumumab Market, by Type
-
10.2 Latin America, Middle East and Africa Daratumumab Market, by Application
-
10.3 Latin America, Middle East and Africa Daratumumab Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Daratumumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Daratumumab Company Profiles
-
11.1 Johnson＆Johnson
-
11.1.1 Johnson＆Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Johnson＆Johnson Daratumumab Product Profiles, Application and Specification
-
11.1.3 Johnson＆Johnson Daratumumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Daratumumab Industry Investment Prospect and Risk Assessment
-
12.1 Daratumumab Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Daratumumab Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure China Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Global Daratumumab Production Value and Growth Rate (2017-2028)
-
Figure China Daratumumab Production Value and Growth Rate (2017-2028)
-
Figure Global Daratumumab Market Size and Growth Rate of 100mg Injection (2017-2028)
-
Figure Global Daratumumab Market Size and Growth Rate of 400mg Injection (2017-2028)
-
Figure Global Daratumumab Market Size and Growth Rate of Multiple Myeloma (2017-2028)
-
Figure Global Daratumumab Market Size and Growth Rate of Diffuse Large B Cell Lymphoma (2017-2028)
-
Figure Global Daratumumab Market Size and Growth Rate of Follicular Lymphoma (2017-2028)
-
Figure Global Daratumumab Market Size and Growth Rate of Mantle Cell Lymphoma (2017-2028)
-
Figure Global Daratumumab Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Daratumumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Daratumumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Daratumumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Daratumumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Daratumumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Daratumumab Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Daratumumab Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Daratumumab Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Daratumumab Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Daratumumab Market Share, by Manufacturer in 2021
-
Figure Global and China Daratumumab Market Share, by Manufacturer in 2022
-
Table Global Daratumumab Sales Volume, by Type (2017-2028)
-
Table Global Daratumumab Sales Volume Share, by Type (2017-2028)
-
Figure Global Daratumumab Sales Volume Share, by Type (2017-2028)
-
Table Global Daratumumab Sales Value, by Type (2017-2028)
-
Table Global Daratumumab Sales Value Share, by Type (2017-2028)
-
Figure Global Daratumumab Price Trend, by Type (2017-2028)
-
Table China Daratumumab Sales Volume, by Type (2017-2028)
-
Table China Daratumumab Sales Volume Share, by Type (2017-2028)
-
Figure China Daratumumab Sales Volume Share, by Type (2017-2028)
-
Table China Daratumumab Sales Value, by Type (2017-2028)
-
Table China Daratumumab Sales Value Share, by Type (2017-2028)
-
Figure China Daratumumab Price Trend, by Type (2017-2028)
-
Table Global Daratumumab Sales Volume, by Application (2017-2028)
-
Table Global Daratumumab Sales Volume Share, by Application (2017-2028)
-
Figure Global Daratumumab Sales Volume Share, by Application (2017-2028)
-
Table Global Daratumumab Sales Value, by Application (2017-2028)
-
Table Global Daratumumab Sales Value Share, by Application (2017-2028)
-
Figure Global Daratumumab Sales Value Share, by Application (2017-2028)
-
Table China Daratumumab Sales Volume, by Application (2017-2028)
-
Table China Daratumumab Sales Volume Share, by Application (2017-2028)
-
Figure China Daratumumab Sales Volume Share, by Application (2017-2028)
-
Table China Daratumumab Sales Value, by Application (2017-2028)
-
Table China Daratumumab Sales Value Share, by Application (2017-2028)
-
Figure China Daratumumab Sales Value Share, by Application (2017-2028)
-
Figure China Daratumumab Production, Import, Consumption and Export (2017-2022)
-
Figure North America Daratumumab Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Daratumumab Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Daratumumab Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Daratumumab Production, Import, Consumption and Export (2017-2022)
-
Table North America Daratumumab Sales Volume, by Type (2017-2028)
-
Table North America Daratumumab Sales Volume Share, by Type (2017-2028)
-
Figure North America Daratumumab Sales Volume Share, by Type (2017-2028)
-
Table North America Daratumumab Sales Volume, by Application (2017-2028)
-
Table North America Daratumumab Sales Volume Share, by Application (2017-2028)
-
Figure North America Daratumumab Sales Volume Share, by Application (2017-2028)
-
Figure United States Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure United States Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Canada Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Daratumumab Sales Value and Growth Rate (2017-2028)
-
Table Europe Daratumumab Sales Volume, by Type (2017-2028)
-
Table Europe Daratumumab Sales Volume Share, by Type (2017-2028)
-
Figure Europe Daratumumab Sales Volume Share, by Type (2017-2028)
-
Table Europe Daratumumab Sales Volume, by Application (2017-2028)
-
Table Europe Daratumumab Sales Volume Share, by Application (2017-2028)
-
Figure Europe Daratumumab Sales Volume Share, by Application (2017-2028)
-
Figure Germany Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure UK Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure UK Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure France Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure France Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Italy Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Spain Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Poland Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Russia Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Daratumumab Sales Value and Growth Rate (2017-2028)
-
Table APAC Daratumumab Sales Volume, by Type (2017-2028)
-
Table APAC Daratumumab Sales Volume Share, by Type (2017-2028)
-
Figure APAC Daratumumab Sales Volume Share, by Type (2017-2028)
-
Table APAC Daratumumab Sales Volume, by Application (2017-2028)
-
Table APAC Daratumumab Sales Volume Share, by Application (2017-2028)
-
Figure APAC Daratumumab Sales Volume Share, by Application (2017-2028)
-
Figure China Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure China Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Japan Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure India Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure India Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Daratumumab Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Daratumumab Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Daratumumab Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Daratumumab Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Daratumumab Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Daratumumab Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Daratumumab Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Daratumumab Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Daratumumab Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Daratumumab Sales Value and Growth Rate (2017-2028)
-
Table Johnson＆Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Johnson＆Johnson Product Profiles, Application and Specification
-
Table Johnson＆Johnson Daratumumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
